PF-06650808

PF-06650808 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-06650808, covering 2019-03-29 to 2019-03-29. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors [Phase 1]